This page contains exclusive content for the member of the following sections: TTS. Log in to view.
Presenter: Ping, Zhang, Royal Oak, United States
Authors: Zhang P., Farinola M., Samarapungavan D., Rooney M., Hicks S., Cohn S., Reddy G., Rocher L., Dumler F., Parasuraman R.
LABORATORY IMMUNOLOGY AND KIDNEY TRANSPLANTATION
P.L. Zhang1, M.A. Farinola2, D. Samarapungavan2, M.T. Rooney3, S.K. Hicks2, S.R. Cohn2, G.H. Reddy2, L.L. Rocher2, F. Dumler2, R.K. Parasuraman2
1Anatomic Pathology, Nephrology And Transplantation, William Beamont Hospital, Royal Oak/UNITED STATES OF AMERICA, 2Anatomic Pathology, Nephrology And Transplantation, William Beaumont Hospital, Royal Oak/UNITED STATES OF AMERICA, 3Anatomic Pathology, Nephrology And Transplantation, William Beaumont Hospital, Royal Oak/MI/UNITED STATES OF AMERICA
Body: Introduction. The Banff criteria (from 2005 to 2009) use "T cell mediated rejection" to indicate acute cellular rejection. Vasculitis in smaller arteries is an important diagnostic criterion for moderate and severe "T cell mediated rejection". The renal allograft endothelium is a significant target of inflammatory response mediated tissue damage. Medium size arteries (arcuate arteries) are mostly absent in routine allograft biopsies, so identification of vasculitis relies on its identification in small arteries (arterioles to interlobar arteries). Although inflammation in terminal vessels such as the glomerular capillaries has been previously recognized, their role in grading the rejection process is not well characterized. We therefore evaluated the expression of CD3 positive T lymphocytes and CD68 positive macrophages in glomeruli, small arteries and arcuate arteries of nephrectomy specimens obtained from transplant and renal tumor patients. Methods. The study group included 21 renal explant subjects with non-reversible moderate to severe cellular rejection (IIa to III) and/or severe chronic allograft nephropathy. The control group comprised 17 individuals with nephrectomy for renal tumors. In each case, a large renal section from cortex to medulla was stained for CD3 and CD68 by immunohistochemical method. CD3 positive T lymphocytes and CD68 positive macrophages per balanced high power field (BHPF) were counted in glomeruli, interlobar and arcuate arteries. Results. In control kidney sections, neither CD3 positive T lymphocytes nor CD68 positive macrophages were noted in glomeruli, interlobar arteries or arcuate arteries. In the study group, 15/21 study cases had antibody mediated rejection. Also in the study group, positive CD3 counts in glomeruli were significantly correlated to both interlobar and arcuate artery counts by linear regression analysis (r and p values are listed in the Table 1) as T lymphocyte and macrophage counts are also presented in the table for the three areas studied.
Table 1 | T cells (#/BHPF) | r and p vs glomeruli | Macrophages (#/BHPF) | r and p vs glomeruli |
Interlobar Arteries | 8.7 ± 1.7 | 0.61; 0.003 | 10.8 ± 1.2 | 0.57; 0.007 |
Arcuate Arteries | 8.9 ± 0.9 | 0.54; 0.012 | 10.0 ± 0.7 | 0.44; 0.045 |
Glomeruli | 13.6 ± 2.2 | - | 11.2 ± 0.6 | - |
Disclosure: All authors have declared no conflicts of interest.
By viewing the material on this site you understand and accept that:
The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada